Determining the origin of genome aberrations improves the positive predictive value of NIPT for 22q11.2 deletion syndrome

Abstract Non-invasive prenatal testing (NIPT) has been endorsed by the American College of Medical Genetics and Genomics as the preferred method for screening fetal 22q11.2 deletion syndrome (22q11.2 DS). Maternal genomic aberrations represent a significant source of false positives in NIPT, and the...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiale Xiang, Xiangzhong Sun, Jiguang Peng, Hongfu Zhang, Jiankun Shen, Jingrou Li, Hongyu Li, Lanping Hu, Jingjing Zhang, Shihao Zhou, Sihu Xu, Yun Yang, Jun He, Zhiyu Peng
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-10446-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849763579753922560
author Jiale Xiang
Xiangzhong Sun
Jiguang Peng
Hongfu Zhang
Jiankun Shen
Jingrou Li
Hongyu Li
Lanping Hu
Jingjing Zhang
Shihao Zhou
Sihu Xu
Yun Yang
Jun He
Zhiyu Peng
author_facet Jiale Xiang
Xiangzhong Sun
Jiguang Peng
Hongfu Zhang
Jiankun Shen
Jingrou Li
Hongyu Li
Lanping Hu
Jingjing Zhang
Shihao Zhou
Sihu Xu
Yun Yang
Jun He
Zhiyu Peng
author_sort Jiale Xiang
collection DOAJ
description Abstract Non-invasive prenatal testing (NIPT) has been endorsed by the American College of Medical Genetics and Genomics as the preferred method for screening fetal 22q11.2 deletion syndrome (22q11.2 DS). Maternal genomic aberrations represent a significant source of false positives in NIPT, and there are currently no solutions that effectively address this challenge. We have devised an innovative NIPT bioinformatics pipeline designed to discern the origins of copy number variations (CNVs). Then, we recruited a cohort of 39cases of 22q11.2 DS to validate the effectiveness of our methodology. Follow-up tests including amniocentesis and genome sequencing of maternal leukocytes were conducted. Leveraging a dataset of over 900 CNVs, we developed a new pipeline that classifies CNVs into those of fetal, maternal, and maternal-fetal origin based on NIPT data. The use of our pipeline led to a notable increase in the positive predictive value of NIPT for detecting 22q11.2 DS from 87% (34/39) to 94% (34/36). Furthermore, our approach has the potential to reduce the number of invasive tests by 8% (3/39). Our innovative and reliable bioinformatics pipeline has enabled the accurate differentiation of CNV origin into fetal, maternal, and maternal-fetal categories. Incorporating this pipeline into the analytical workflow could reduce false positives in NIPT results and minimize the need for invasive prenatal diagnoses.
format Article
id doaj-art-751049a18c344764bc8db70a623d3f8e
institution DOAJ
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-751049a18c344764bc8db70a623d3f8e2025-08-20T03:05:22ZengNature PortfolioScientific Reports2045-23222025-07-011511910.1038/s41598-025-10446-8Determining the origin of genome aberrations improves the positive predictive value of NIPT for 22q11.2 deletion syndromeJiale Xiang0Xiangzhong Sun1Jiguang Peng2Hongfu Zhang3Jiankun Shen4Jingrou Li5Hongyu Li6Lanping Hu7Jingjing Zhang8Shihao Zhou9Sihu Xu10Yun Yang11Jun He12Zhiyu Peng13BGI GenomicsBGI GenomicsBGI GenomicsBGI GenomicsBGI GenomicsBGI GenomicsHunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal UniversityHunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal UniversityHunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal UniversityHunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal UniversityBGI GenomicsBGI GenomicsHunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal UniversityBGI GenomicsAbstract Non-invasive prenatal testing (NIPT) has been endorsed by the American College of Medical Genetics and Genomics as the preferred method for screening fetal 22q11.2 deletion syndrome (22q11.2 DS). Maternal genomic aberrations represent a significant source of false positives in NIPT, and there are currently no solutions that effectively address this challenge. We have devised an innovative NIPT bioinformatics pipeline designed to discern the origins of copy number variations (CNVs). Then, we recruited a cohort of 39cases of 22q11.2 DS to validate the effectiveness of our methodology. Follow-up tests including amniocentesis and genome sequencing of maternal leukocytes were conducted. Leveraging a dataset of over 900 CNVs, we developed a new pipeline that classifies CNVs into those of fetal, maternal, and maternal-fetal origin based on NIPT data. The use of our pipeline led to a notable increase in the positive predictive value of NIPT for detecting 22q11.2 DS from 87% (34/39) to 94% (34/36). Furthermore, our approach has the potential to reduce the number of invasive tests by 8% (3/39). Our innovative and reliable bioinformatics pipeline has enabled the accurate differentiation of CNV origin into fetal, maternal, and maternal-fetal categories. Incorporating this pipeline into the analytical workflow could reduce false positives in NIPT results and minimize the need for invasive prenatal diagnoses.https://doi.org/10.1038/s41598-025-10446-8NIPT22q11.2 deletion syndromeMaternal CNVFalse positivePositive predictive value
spellingShingle Jiale Xiang
Xiangzhong Sun
Jiguang Peng
Hongfu Zhang
Jiankun Shen
Jingrou Li
Hongyu Li
Lanping Hu
Jingjing Zhang
Shihao Zhou
Sihu Xu
Yun Yang
Jun He
Zhiyu Peng
Determining the origin of genome aberrations improves the positive predictive value of NIPT for 22q11.2 deletion syndrome
Scientific Reports
NIPT
22q11.2 deletion syndrome
Maternal CNV
False positive
Positive predictive value
title Determining the origin of genome aberrations improves the positive predictive value of NIPT for 22q11.2 deletion syndrome
title_full Determining the origin of genome aberrations improves the positive predictive value of NIPT for 22q11.2 deletion syndrome
title_fullStr Determining the origin of genome aberrations improves the positive predictive value of NIPT for 22q11.2 deletion syndrome
title_full_unstemmed Determining the origin of genome aberrations improves the positive predictive value of NIPT for 22q11.2 deletion syndrome
title_short Determining the origin of genome aberrations improves the positive predictive value of NIPT for 22q11.2 deletion syndrome
title_sort determining the origin of genome aberrations improves the positive predictive value of nipt for 22q11 2 deletion syndrome
topic NIPT
22q11.2 deletion syndrome
Maternal CNV
False positive
Positive predictive value
url https://doi.org/10.1038/s41598-025-10446-8
work_keys_str_mv AT jialexiang determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT xiangzhongsun determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT jiguangpeng determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT hongfuzhang determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT jiankunshen determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT jingrouli determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT hongyuli determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT lanpinghu determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT jingjingzhang determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT shihaozhou determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT sihuxu determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT yunyang determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT junhe determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome
AT zhiyupeng determiningtheoriginofgenomeaberrationsimprovesthepositivepredictivevalueofniptfor22q112deletionsyndrome